» Articles » PMID: 18849300

Menstrual and Reproductive Factors in Association with Lung Cancer in Female Lifetime Nonsmokers

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2008 Oct 14
PMID 18849300
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Cigarette smoking is irrefutably the strongest risk factor for lung cancer; however, approximately 25% of cases worldwide occur among nonsmokers. The age-adjusted annual incidence rate of lung cancer in Shanghai, a region where relatively few women smoke cigarettes, is one of the highest in the world. To help further elucidate the etiology of lung cancer among nonsmokers, the authors examined hormonal factors among women who were lifetime nonsmokers. They analyzed data from the prospective Shanghai Women's Health Study, which recruited Chinese women aged 40-70 years between 1996 and 2000 from selected urban communities. The current analysis included 71,314 women (n = 220 cases) who were lifetime nonsmokers and had no history of cancer at baseline. Later age at menopause (> or =51 vs. <46 years; hazard ratio (HR) = 0.63, 95% confidence interval (CI): 0.40, 1.00), longer reproductive period (> or =36 vs. <31 years; HR = 0.60, 95% CI: 0.39, 0.93), higher parity (> or =4 vs. 0 children; HR = 0.42, 95% CI: 0.19, 0.90), and intrauterine device use (HR = 0.59, 95% CI: 0.41, 0.86) were associated with decreased risks of lung cancer. This large prospective study suggests a potential role for hormonal factors in the etiology of lung cancer among nonsmoking women.

Citing Articles

Development and validation of a nomogram for predicting histologic subtypes of subpleural non-small cell lung cancer using ultrasound parameters and clinical data.

Mao F, Shen M, Zhang Y, Chen H, Cong Y, Zhu H Front Oncol. 2024; 14:1477450.

PMID: 39582539 PMC: 11581939. DOI: 10.3389/fonc.2024.1477450.


The Innate Immune System and the TRAIL-Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females.

May L, Hu B, Jerajani P, Jagdeesh A, Alhawiti O, Cai L Cancer Res. 2024; 84(24):4140-4155.

PMID: 39312191 PMC: 11649478. DOI: 10.1158/0008-5472.CAN-24-0585.


Menstrual and reproductive factors associated with risk of breast cancer among Indian women: a cross sectional study from National Family Health Survey, 2019-21.

Das U, Soren S, Kar N Arch Public Health. 2024; 82(1):55.

PMID: 38654339 PMC: 11041000. DOI: 10.1186/s13690-024-01266-9.


Reproductive factors and risk of lung cancer among 300,000 Chinese female never-smokers: evidence from the China Kadoorie Biobank study.

Elbasheer M, Bohrmann B, Chen Y, Lv J, Sun D, Wu X BMC Cancer. 2024; 24(1):384.

PMID: 38532314 PMC: 10964706. DOI: 10.1186/s12885-024-12133-9.


Lung cancer in females-sex-based differences from males in epidemiology, biology, and outcomes: a narrative review.

Gee K, Yendamuri S Transl Lung Cancer Res. 2024; 13(1):163-178.

PMID: 38405003 PMC: 10891406. DOI: 10.21037/tlcr-23-744.


References
1.
Brenner A, Wang Z, Kleinerman R, Lei S, Metayer C, Wang W . Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994-1998. J Epidemiol. 2003; 13(1):22-8. PMC: 9538613. DOI: 10.2188/jea.13.22. View

2.
Zhu B, Conney A . Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998; 19(1):1-27. DOI: 10.1093/carcin/19.1.1. View

3.
Zang E, Wynder E . Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996; 88(3-4):183-92. DOI: 10.1093/jnci/88.3-4.183. View

4.
Verthelyi D . Sex hormones as immunomodulators in health and disease. Int Immunopharmacol. 2001; 1(6):983-93. DOI: 10.1016/s1567-5769(01)00044-3. View

5.
Thomas F, Renaud F, Benefice E, De Meeus T, Guegan J . International variability of ages at menarche and menopause: patterns and main determinants. Hum Biol. 2001; 73(2):271-90. DOI: 10.1353/hub.2001.0029. View